Abstract
This chapter describes the process of collecting and analyzing information in order to make decisions which help a project move through a key early stage in drug discovery. It explains, in general, the sources of hits for a drug discovery program and explores the link between potency and efficiency in evaluating lead matter. The chapter then illustrates the collection of both pharmacokinetic data as well as safety data, and describes the relevance of that data and the process of using it to make decisions. Of course, there is no one “right” or “wrong” way to do the work contained in this chapter, but the practice of efficiently building a network of information on compounds, and then using that to make informed decisions can help to shift the odds of success in drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gillespie P, Goodnow RA Jr (2004) The hit-to-lead process in drug discovery. In: Doherty A (ed) Annual reports in medicinal chemistry. Elsevier, Oxford, p 293
Keseru GM, Makara GM (2006) Drug Discov Today 11:741
Leach AR, Hann MM, Burrows JN, Griffen EJ (2006) Mol Biosyst 2:429
Bleicher KH, Bohm H-J, Muller K, Alanine AI (2003) Nat Rev Drug Discov 2:369
Williams DH, Stephens E, O'Brien DP, Zhou M (2004) Angew Chem Int Ed Engl 43:6596
Nassar A-EF, Lopez-Anaya A (2004) Curr Opin Drug Discov 7:126
Lundqvist T (2005) Curr Opin Drug Discov 8:513
Carr RA, Congreve M, Murray CW, Rees DC (2005) Drug Discov Today 10:987
Stewart L, Clark R, Behnke C (2002) Drug Discov Today 7:187
Goodwill KE, Tennant MG, Stevens RC (2001) Drug Discov Today 6:S113
Rees DC, Congreve M, Murray CW, Carr R (2004) Nat Rev Drug Discov 3:660
Laird ER, Blake JF (2004) Curr Opin Drug Discov 7:354
Klebe G (2006) Drug Discov Today 11:580
Zartler ER, Mo H (2007) Curr Top Med Chem 7:1592
Hajduk PJ, Gerfin T, Boehlen J-M, Haeberli M, Marek D, Fesik SW (1999) J Med Chem 42:2315
Dalvit C, Flocco M, Knapp S, Mostardini M, Perego R, Stockman BJ, Veronesi M, Varasi M (2002) J Am Chem Soc 124:7702
Liu B, Li S, Hu J (2004) Am J Pharmacogenomics 4:263
Boozer C, Kim G, Cong S, Guan HW, Londergan T (2006) Curr Opin Biotech 17:400
Rich R, Hoth LR, Goeghegan KF, Brown TA, LeMotte PK, Simons SP, Hensley P, Myszka DG (2002) Proc Natl Acad Sci USA 99:8562
Cooper MA (2006) Drug Discov Today 11:1068
Doyle ML (1997) Curr Opin Biotech 8:31
Weber PC, Salemme FR (2003) Curr Opin Struct Biol 13:115
Dowling MR, Charlton SJ (2006) Br J Pharmacol 148:927
Huber W (2005) J Mol Recognit 18:273
Cik M, Jurzak MR (2006) High-throughput and high content screening. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.32
Schnurr B, Ahrens T, Regenass U (2006) Optical assays in drug discovery In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.27
Ullmann D (2006) Fluorescence screening assays. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.28
Weissman A, Keefer J, Miagkov A, Sathyamoorthy M, Perschke S, Wang FL (2006) Cell-based screening assays. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 3.29
Kuntz ID, Sharp KA, Kollman PA (1999) Proc Natl Acad Sci USA 96:9997
Hopkins AL, Groom CR, Alex A (2004) Drug Discov Today 9:430
Hajduk PJ (2006) J Med Chem 49:6972
Lipinski CA, Lombardo F, Dominy BW, Freeny PJ (1997) Adv Drug Deliv Rev 23:3
Lipinski CA (2001) J Pharmacol Toxicol 44:235
Hajduk PJ, Greer J (2007) Nat Rev Drug Discov 6:211
Teague SJ, Davis AM, Leeson PD, Oprea T (1999) Angew Chem Int Ed Engl 38:3743
Hann MM, Leach AR, Harper G (2001) J Chem Inf Comput Sci 41:856
Proudfoot JR (2002) Bioorg Med Chem Lett 12:1647
Wunberg T, Hendrix M, Hillisch A, Lobell M, Meier H, Schmeck C, Wild H, Hinzen B (2006) Drug Discov Today 11:175
Hann MM, Oprea TI (2004) Curr Opin Chem Biol 8:255
Van de Waterbeemd H, Smith DA, Beaumont K, Walker DK (2001) J Med Chem 44:1313
Van de Waterbeemd H, Smith DA, Jones BC (2001) J Comp Aid Mol Des 15:273
Riley RJ, Martin IJ, Cooper AE (2002) Curr Drug Metab 3:527
Venkatakrishnan K, von Moltke LL, Obach RS, Greenblatt DJ (2003) Curr Drug Metab 4:423
Di L, Kerns EH (2005) Curr Opin Drug Discov Dev 8:495
Parmentier Y, Bossant M-J, Bertrand M, Walther B (2006) In vitro studies of drug metabolism. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.10
Trager WF (2006) Principles of drug metabolism 1: redox reactions. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.05
Testa B (2006) Principles of drug metabolism 2: hydrolysis and conjugation reactions. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.06
Lin JH, Wong BK (2002) Curr Drug Metab 3:623
Obach RS (2001) Curr Opin Drug Discov Dev 4:36
Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, Tucker GT, Rostami-Hodjegan A (2007) Curr Drug Metab 8:33
Brown HS, Griffin M, Houston JB (2007) Drug Metab and Dispos 35:293
Grime K, Riley RJ (2006) Curr Drug Metab 7:251
Nassar A-EF, Kamel AM, Clarimont C (2004) Drug Discov Today 9:1020
Balimane PV, Han Y-H, Chong S (2006) AAPS J 8:E1
Artursson P, Neuhoff S, Matsson P, Tavelin S (2006) Passive permeability and active transport models for the prediction of oral absorption. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.11
Kansy M, Senner F, Gubernator K (1998) J Med Chem 41:1007
Galinis-Luciani D, Nguyen L, Yazdanian M (2007) J Pharm Sci 96:2886
Avdeef A, Bendels S, Di L, Faller B, Kansy M, Sugano K, Yamauchi Y (2007) J Pharm Sci 96:2893
Yu X-Q, Xue CC, Wang G, Zhou S-F (2007) Curr Drug Metab 8:787
Fearn RA, Hirst BH (2006) Environ Toxicol Pharmacol 21:168
Abbott NJ (2006) In vitro models for examining and predicting brain uptake of drugs. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5.13
Malkia A, Murtomaki L, Urtti A, Kontturi K (2004) Eur J Pharm Sci 23:13
Alsenz J, Kansy M (2007) Adv Drug Deliv Rev 59:546
Bergstrom CAS, Wassvik CM, Johansson K, Hubatsch I (2007) J Med Chem 50:5858
Kola I, Landis J (2004) Nat Rev Drug Discov 3:711
Pearlstein R, Vaz R, Rampe D (2003) J Med Chem 46:2017
Raschi E, Vasina V, Poluzzi E, De Ponti F (2008) Pharmacol Res 57:181
Snyders DJ, Chaudhury A (1996) Mol Pharmacol 49:949
Kiehn J, Lacerda AE, Wible B, Brown AM (1996) Circulation 94:2572
Dubin AE, Nasser N, Rohrbacher J, Hermans AN, Marrannes R, Grantham C, Van Rossem K, Cik M, Chaplan SR, Gallacher D, Xu J, Guia A, Byrne NG, Mathes C (2005) J Biomol Screen 10:168
Raab CE, Butcher JW, Connolly TM, Karczewski J, Yu N, Staskiewicz S, Liverton N, Dean DC, Melillo DG (2006) Bioorg Med Chem Lett 16:1692
Singleton DH (2007) J Med Chem 50:2391
Fernandez D, Ghanta A, Kauffman GW, Sanguinetti MC (2004) J Biol Chem 279:10120
Cavalli A, Poluzzi E, De Ponti F, Recanatini M (2002) J Med Chem 45:3844
Aronov A (2006) J Med Chem 49:6917
Cianchetta G, Li Y, Kang J, Rampe D, Fravolini A, Cruciani G, Vaz RJ (2005) Bioorg Med Chem Lett 15:3637
Song M, Clark M (2006) J Chem Inf Model 46:392
Waring MJ, Johnstone C (2007) Bioorg Med Chem Lett 17:1759
Muto S, Miyata K, Tsutsumibata C, Daigo H, Ooro T, Sugiura K, Baba H, Uno Y (2006) Top Issues Appl Microbiol Biotech 1
Kirpnick Z, Homiski M, Rubitski E, Repnevskaya M, Howlett N, Aubrecht J, Schiestl RH (2005) Mutat Res 582:116
Avlasevich SL, Bryce SM, Cairns SE, Dertinger SD (2006) Environ Mol Mutagen 47:56
Greene N (2006) Computational models to predict toxicity. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, Sect 5
Egan WJ, Zlokarnik G, Grootenhuis PDJ (2004) Drug Discov Today Tech 1:381
Contrera JF, Matthews EJ, Kruhlak NL, Benz RD (2005) Regul Toxicol Pharmacol 43:313
Murray M (2005) Mod Biopharm 4:1603
Hayashi M, Kamata E, Hirose A, Takahashi M, Morita T, Ema M (2005) Mutat Res 588:129
Matthews EJ, Kruhlak NL, Cimino MC, Benz RD, Contrera JF (2006) Regul Toxicol Pharmacol 44:97
Didziapetris R, Reynolds DP, Japertas P, Zmuidinavicius D, Petrauskas A (2006) Curr Comp Drug Des 2:95
Snyder RD (2007) Mutat Res 623:72
Hop CECA, Kalgutkar A, Soglia J (2006) Annu Rep Med Chem 41:369
Williams DP, Park BK (2003) Drug Discov Today 8:1044
Walgren JL, Mitchell MD, Thompson DC (2005) Crit Rev Toxicol 35:325
Park BK, Kitteringham NR, Maggs JL, Pirmohamed M, Williams DP (2005) Annu Rev Pharmacol Toxicol 45:177
Roth RA, Luyendyk JP, Maddox JF, Ganey PE (2003) J Pharmacol Exp Ther 307
Kalgutkar AS, Obach RS, Maurer TS (2007) Curr Drug Metab 8:407
Blagg J (2006) Annu Rep Med Chem 41:369
Soglia JR, Harriman SP, Zhao S, Barberia J, Cole MJ, Boyd JG, Contillo LG (2004) J Pharm Biomed Anal 36:105
Zheng J, Ma L, Xin B, Olah T, Griffith Humphreys W, Zhu M (2007) Chem Res Toxicol 20:757
Poulain R, Horvath D, Bonnet B, Eckhoff C, Chapelain B, Bodinier M-C, Deprez B (2001) J Med Chem 44:3391
Fliri AF, Loging WT, Thadeio PF, Volkmann RA (2005) Proc Natl Acad Sci USA 102:261
Schnecke V, Bostrom J (2006) Drug Discov Today 11:43
Beresford AP, Segall M, Tarbit MH (2004) Curr Opin Drug Discov Dev 7:36
Ekins S, Swaan PW (2004) Development of computational models for enzymes, transporters, channels, and receptors relevant to ADME/tox. In: Lipkowitz KB, Larter R, Cundari TR (eds) Reviews in computational chemistry, vol. 20. Wiley, Hoboken, NJ, chap 6
Penzotti J, Landrum GA, Putta S (2004) Curr Opin Drug Discov Dev 7:49
Bergstrom CAS (2005) Expert Opin Drug Metab Toxicol 1:613
Yu H, Adedoyin A (2003) Drug Discov Today 8:852
Davies JW, Glick M, Jenkins JL (2006) Curr Opin Chem Biol 10:343
Faller B, Ertl P (2007) Adv Drug Deliv Rev 59:533
Delaney JS (2005) Drug Discov Today 10:289
Bergstrom CAS (2005) Expert Opin Drug Metab Toxicol 1:613
Arimoto R (2006) Curr Top Med Chem 6:1609
Snyder RD, Smith MD (2005) Drug Discov Today 10:1119
Clark DE (2005) Computational prediction of blood-brain barrier permeation. In Doherty A (ed) Annual reports in medicinal chemistry. Elsevier, Oxford, p 413
Hutzler JM, Messing DM, Wienkers LC (2005) Curr Opin Drug Discov Dev 8:51
Ekins S, Balakin KV, Savchuk N, Ivanenkov Y (2006) J Med Chem 49:5059
Johnson SR, Yue H, Conder ML, Shi H, Doweyko AM, Lloyd J, Levesque P (2007) Bioorg Med Chem 15:6182
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Freeman-Cook, K.D., Kung, D.W. (2009). Hit Triage: Medicinal Chemistry Strategies to Improve the Odds of Success in Discovery. In: Hayward, M.M., et al. Lead-Seeking Approaches. Topics in Medicinal Chemistry, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7355_2009_1
Download citation
DOI: https://doi.org/10.1007/7355_2009_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-01074-3
Online ISBN: 978-3-642-01075-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)